Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vinay Prasad
Biotech
‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections
“The stories are so outrageous,” Sen. Johnson told Bloomberg about recent FDA rebuffs. “It just appears that they’re looking for excuses to say no.”
Gabrielle Masson
Mar 10, 2026 11:10am
CBER Director Vinay Prasad to depart FDA—again
Mar 6, 2026 5:30pm
Senior FDA official fires back at uniQure amid controversy
Mar 5, 2026 3:33pm
Fierce Pharma
Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad
Mar 3, 2026 4:58pm
Trump met with Makary before FDA’s Moderna walkback: report
Feb 19, 2026 11:30am
FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad
Feb 3, 2026 11:40am
